Companies / Santa Cruz Biotechnology / Smad4 (B-8) AC
Santa Cruz Biotechnology

Smad4 (B-8) AC | Santa Cruz Biotechnology

mouse monoclonal IgG1; Smad4 Antibody (B-8) is an IgG1 κ mouse monoclonal Smad4 antibody that detects the Smad4 protein of mouse, rat and human origin by WB, IP, IF, IHC(P), FCM and ELISA. Smad4 Antibody (B-8) is available as both the non-conjugated anti-Smad4 antibody form, as well as multiple conjugated forms of anti-Smad4 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Smad4 (also designated DPC4) is a member of the Smad family of proteins, which are the mammalian homologs of the Drosophila Mothers against dpp (Mad) . Smad proteins have been implicated as downstream effectors of TGFβ/BMP signaling. Smad1 (also designated Madr1 or JV4-1), Smad5 and mammalian Smad8 (also designated Smad9 or MADH6) are effectors of BMP2 and BMP4 function while Smad2 (also designated Madr2 or JV18-1) and Smad3 are involved in TGFβ and activin-mediated growth modulation. The Smad4 Antibody (B-8) shows specificity for Smad4, which has been shown to mediate all of the above activities through interaction with various Smad family members. Smad6 and Smad7 regulate the response to activin/TGFβ signaling by interfering with TGFβ-mediated phosphorylation of other Smad family members.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.